Therapeutic strategy for pandrug-resistant Klebsiella pneumoniae severe infections: short-course treatment with colistin increases the in vivo and in vitro activity of double carbapenem regimen
Open Access
- 1 April 2015
- journal article
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 33, 132-134
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Synergistic activity and effectiveness of a double-carbapenem regimen in pandrug-resistant Klebsiella pneumoniae bloodstream infectionsJournal of Antimicrobial Chemotherapy, 2014
- Synergistic Activity of Colistin plus Rifampin against Colistin-Resistant KPC-Producing Klebsiella pneumoniaeAntimicrobial Agents and Chemotherapy, 2013
- High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortalityClinical Microbiology and Infection, 2013
- A sensitive and specific phenotypic assay for detection of metallo-β-lactamases and KPC in Klebsiella pneumoniae with the use of meropenem disks supplemented with aminophenylboronic acid, dipicolinic acid and cloxacillinClinical Microbiology and Infection, 2011
- Toxicity of polymyxins: a systematic review of the evidence from old and recent studiesCritical Care, 2006